TRIUMPH-4 is the first pivotal trial to confirm that the weight-loss signal seen in Phase 2 scales with longer exposure and higher doses, and it adds several new secondary findings that reshape how researchers think about 9 mg and 12 mg as working doses
If constipation is intolerable on one medication, switching to the other may help, but it is not guaranteed
The mechanism involves inhibition of the NF-B signaling pathways, a central regulator of genes involved in inflammation (Figure 3)
The advantages are substantial
Hold the pen or autoinjector at a 90-degree angle to your skin (perpendicular), insert the needle with a quick, dart-like motion, and inject the medication according to your device's instructions
Common early complaints can include: Nausea or a mildly unsettled stomach Feeling full after smaller meals Reduced interest in food Bloating or belching Indigestion or heartburn Diarrhea Constipation Abdominal discomfort Fatigue These symptoms overlap with adverse reactions listed in current prescribing information for Wegovy and Zepbound
